S&P 500   4,591.67 (+1.17%)
DOW   35,227.03 (+1.87%)
QQQ   386.20 (+0.80%)
AAPL   165.32 (+2.15%)
MSFT   326.19 (+0.98%)
FB   317.87 (+3.59%)
GOOGL   2,863.10 (+0.81%)
AMZN   3,427.37 (+1.11%)
TSLA   1,009.01 (-0.59%)
NVDA   300.37 (-2.14%)
BABA   123.60 (+10.40%)
NIO   32.34 (+0.59%)
CGC   10.15 (+1.60%)
AMD   139.06 (-3.44%)
GE   96.01 (+3.49%)
MU   82.45 (+1.02%)
T   23.28 (-0.77%)
F   19.22 (+0.42%)
DIS   150.37 (+2.84%)
PFE   51.48 (-5.14%)
AMC   28.79 (-0.76%)
ACB   5.97 (+2.58%)
BA   205.88 (+3.72%)
S&P 500   4,591.67 (+1.17%)
DOW   35,227.03 (+1.87%)
QQQ   386.20 (+0.80%)
AAPL   165.32 (+2.15%)
MSFT   326.19 (+0.98%)
FB   317.87 (+3.59%)
GOOGL   2,863.10 (+0.81%)
AMZN   3,427.37 (+1.11%)
TSLA   1,009.01 (-0.59%)
NVDA   300.37 (-2.14%)
BABA   123.60 (+10.40%)
NIO   32.34 (+0.59%)
CGC   10.15 (+1.60%)
AMD   139.06 (-3.44%)
GE   96.01 (+3.49%)
MU   82.45 (+1.02%)
T   23.28 (-0.77%)
F   19.22 (+0.42%)
DIS   150.37 (+2.84%)
PFE   51.48 (-5.14%)
AMC   28.79 (-0.76%)
ACB   5.97 (+2.58%)
BA   205.88 (+3.72%)
S&P 500   4,591.67 (+1.17%)
DOW   35,227.03 (+1.87%)
QQQ   386.20 (+0.80%)
AAPL   165.32 (+2.15%)
MSFT   326.19 (+0.98%)
FB   317.87 (+3.59%)
GOOGL   2,863.10 (+0.81%)
AMZN   3,427.37 (+1.11%)
TSLA   1,009.01 (-0.59%)
NVDA   300.37 (-2.14%)
BABA   123.60 (+10.40%)
NIO   32.34 (+0.59%)
CGC   10.15 (+1.60%)
AMD   139.06 (-3.44%)
GE   96.01 (+3.49%)
MU   82.45 (+1.02%)
T   23.28 (-0.77%)
F   19.22 (+0.42%)
DIS   150.37 (+2.84%)
PFE   51.48 (-5.14%)
AMC   28.79 (-0.76%)
ACB   5.97 (+2.58%)
BA   205.88 (+3.72%)
S&P 500   4,591.67 (+1.17%)
DOW   35,227.03 (+1.87%)
QQQ   386.20 (+0.80%)
AAPL   165.32 (+2.15%)
MSFT   326.19 (+0.98%)
FB   317.87 (+3.59%)
GOOGL   2,863.10 (+0.81%)
AMZN   3,427.37 (+1.11%)
TSLA   1,009.01 (-0.59%)
NVDA   300.37 (-2.14%)
BABA   123.60 (+10.40%)
NIO   32.34 (+0.59%)
CGC   10.15 (+1.60%)
AMD   139.06 (-3.44%)
GE   96.01 (+3.49%)
MU   82.45 (+1.02%)
T   23.28 (-0.77%)
F   19.22 (+0.42%)
DIS   150.37 (+2.84%)
PFE   51.48 (-5.14%)
AMC   28.79 (-0.76%)
ACB   5.97 (+2.58%)
BA   205.88 (+3.72%)
OTCMKTS:BAYRY

Bayer Aktiengesellschaft Stock Forecast, Price & News

$12.59
+0.05 (+0.40%)
(As of 12/6/2021 04:00 PM ET)
Add
Compare
Today's Range
$12.51
$12.65
50-Day Range
$12.54
$14.75
52-Week Range
$12.45
$17.34
Volume
1.09 million shs
Average Volume
471,511 shs
Market Capitalization
$49.47 billion
P/E Ratio
251.85
Dividend Yield
3.27%
Beta
1.26
30 days | 90 days | 365 days | Advanced Chart
Receive BAYRY News and Ratings via Email

Sign-up to receive the latest news and ratings for Bayer Aktiengesellschaft and its competitors with MarketBeat's FREE daily newsletter.


Bayer Aktiengesellschaft logo

About Bayer Aktiengesellschaft

Bayer AG engages in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials. It operates through the following segments: Pharmaceuticals, Consumer Health, Crop Science, Animal Health and Covestro. The Pharmaceuticals segment engages in the development, production and marketing of prescription products for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology and ophthalmology; diagnostic imaging equipment and the necessary contrast agents. The Consumer Health segment manufactures and markets products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories. The CropScience segment includes seeds and plant traits, crop protection and nonagricultural pest control. The Animal Health segment offers prescription and nonprescription veterinary products. The Covestro segment provides raw materials for polyurethanes; polycarbonate granules and sheets; raw materials for coatings, adhesives and sealants; and by-products of polyether production and of chlorine production and use. The company was founded by

Headlines

Bayer's (BAYRY) Phase III Study on Nubeqa Combo Meets Goal
December 6, 2021 |  finance.yahoo.com
Bayer CEO Says Labor Costs Will Increase Next Year
November 19, 2021 |  bloomberg.com
See More Headlines

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:BAYRY
Employees
99,538
Year Founded
1863

Sales & Book Value

Annual Sales
$47.29 billion
Cash Flow
$5.60 per share
Book Value
$8.92 per share

Profitability

Net Income
$-11.99 billion
Pretax Margin
-18.34%

Debt

Price-To-Earnings

Miscellaneous

Outstanding Shares
3,929,696,000
Free Float
N/A
Market Cap
$49.47 billion
Optionable
Not Optionable

Company Calendar

Last Earnings
8/05/2021
Today
12/06/2021
Fiscal Year End
12/31/2021

Social Links


MarketRank

Overall MarketRank

2.30 out of 5 stars

Analyst Opinion: 4.3Community Rank: 4.3Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -












Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Frequently Asked Questions

Is Bayer Aktiengesellschaft a buy right now?

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bayer Aktiengesellschaft in the last year. There are currently 4 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Bayer Aktiengesellschaft stock.
View analyst ratings for Bayer Aktiengesellschaft
or view top-rated stocks.

How has Bayer Aktiengesellschaft's stock price been impacted by COVID-19 (Coronavirus)?

Bayer Aktiengesellschaft's stock was trading at $16.58 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, BAYRY shares have decreased by 24.1% and is now trading at $12.59.
View which stocks have been most impacted by COVID-19
.

Are investors shorting Bayer Aktiengesellschaft?

Bayer Aktiengesellschaft saw a drop in short interest in the month of October. As of October 29th, there was short interest totaling 218,300 shares, a drop of 15.9% from the October 14th total of 259,700 shares. Based on an average daily trading volume, of 773,200 shares, the days-to-cover ratio is currently 0.3 days.
View Bayer Aktiengesellschaft's Short Interest
.

How were Bayer Aktiengesellschaft's earnings last quarter?

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) released its earnings results on Thursday, August, 5th. The company reported $0.48 EPS for the quarter, topping the Zacks' consensus estimate of $0.46 by $0.02. The company had revenue of $13.08 billion for the quarter, compared to analyst estimates of $11.83 billion. Bayer Aktiengesellschaft had a trailing twelve-month return on equity of 20.38% and a net margin of 0.34%.
View Bayer Aktiengesellschaft's earnings history
.

How often does Bayer Aktiengesellschaft pay dividends? What is the dividend yield for Bayer Aktiengesellschaft?

Bayer Aktiengesellschaft announced a dividend on Saturday, April 17th. Shareholders of record on Thursday, April 29th will be paid a dividend of $1.3563 per share on Monday, May 10th. This represents a dividend yield of 8.55%. The ex-dividend date is Wednesday, April 28th.
View Bayer Aktiengesellschaft's dividend history
.

Is Bayer Aktiengesellschaft a good dividend stock?

Bayer Aktiengesellschaft pays an annual dividend of $0.41 per share and currently has a dividend yield of 3.27%. The dividend payout ratio of Bayer Aktiengesellschaft is 820.16%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, Bayer Aktiengesellschaft will have a dividend payout ratio of 20.40% next year. This indicates that Bayer Aktiengesellschaft will be able to sustain or increase its dividend.
View Bayer Aktiengesellschaft's dividend history.

What guidance has Bayer Aktiengesellschaft issued on next quarter's earnings?

Bayer Aktiengesellschaft updated its FY 2021 earnings guidance on Tuesday, November, 30th. The company provided earnings per share guidance of $7.660-$7.900 for the period. The company issued revenue guidance of $51.89 billion-$51.89 billion, compared to the consensus revenue estimate of $51.41 billion.

What price target have analysts set for BAYRY?

12 equities research analysts have issued 1 year target prices for Bayer Aktiengesellschaft's stock. Their forecasts range from $60.00 to $60.00. On average, they anticipate Bayer Aktiengesellschaft's stock price to reach $60.00 in the next twelve months. This suggests a possible upside of 376.6% from the stock's current price.
View analysts' price targets for Bayer Aktiengesellschaft
or view top-rated stocks among Wall Street analysts.

Who are Bayer Aktiengesellschaft's key executives?

Bayer Aktiengesellschaft's management team includes the following people:
  • Werner Baumann, Chairman-Management Board & CEO
  • Wolfgang U. Nickl, Chief Financial Officer
  • Bijoy Sagar, Chief Information Technology Officer
  • Marianne de Backer, EVP & Head-Global Business Development & Licensing
  • Frank Rittgen, Head-Mergers & Acquisitions

What is Bayer Aktiengesellschaft's stock symbol?

Bayer Aktiengesellschaft trades on the OTCMKTS under the ticker symbol "BAYRY."

How do I buy shares of Bayer Aktiengesellschaft?

Shares of BAYRY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Bayer Aktiengesellschaft's stock price today?

One share of BAYRY stock can currently be purchased for approximately $12.59.

How much money does Bayer Aktiengesellschaft make?

Bayer Aktiengesellschaft has a market capitalization of $49.47 billion and generates $47.29 billion in revenue each year. The company earns $-11.99 billion in net income (profit) each year or $0.05 on an earnings per share basis.

How many employees does Bayer Aktiengesellschaft have?

Bayer Aktiengesellschaft employs 99,538 workers across the globe.

Does Bayer Aktiengesellschaft have any subsidiaries?

The following companies are subsidiares of Bayer Aktiengesellschaft: AB Seeds Ltd, AB Seeds Sales (2006) Ltd, AO Bayer, Adverio Pharma GmbH, AgrEvo Verwaltungsgesellschaft mbH, AgraQuest Inc., Alcafleu Management GmbH & Co. KG, Algeta, Artificial Muscle Inc, Asklepios BioPharmaceutical, Athenix Corp., Atlantic Breeders S. A. R. L., BUS C.V., Bayer (Proprietary) Limited, Bayer (Schweiz) AG, Bayer 04 Immobilien GmbH, Bayer 04 Leverkusen Fußball GmbH, Bayer A / S, Bayer AB, Bayer AS, Bayer Agriculture BVBA, Bayer Agriculture Limited, Bayer Algerie S. P. A., Bayer Altersversorgung GmbH, Bayer Animal Health GmbH, Bayer Austria Gesellschaft m.b.H., Bayer B.V., Bayer Beteiligungsverwaltung Goslar GmbH, Bayer Beteiligungsverwaltungsgesellschaft mbH & Co. OHG, Bayer Bitterfeld GmbH, Bayer Bulgaria EOOD, Bayer Business Services GmbH, Bayer Canadian Holdings Inc., Bayer Capital Corporation B.V., Bayer Chemicals GmbH, Bayer Consumer Care AG, Bayer Consumer Care Holdings LLC, Bayer Corporation, Bayer CropScience, Bayer CropScience (Portugal)-Produtos para a Agricultura Lda, Bayer CropScience Beteiligungsgesellschaft mit beschränkter Haftung, Bayer CropScience Biologics GmbH, Bayer CropScience Deutschland GmbH, Bayer CropScience Holding Inc., Bayer CropScience Holding SA, Bayer CropScience Holdings Inc., Bayer CropScience Inc., Bayer CropScience LLC, Bayer CropScience LP, Bayer CropScience Limited, Bayer CropScience NV, Bayer CropScience S. L., Bayer CropScience S. r. l., Bayer CropScience Schweiz AG, Bayer CropScience Vermögensverwaltungsgesellschaft mbH, Bayer East Coast LLC, Bayer Essure Inc., Bayer HealthCare Animal Health Inc., Bayer HealthCare Holdings LLC, Bayer HealthCare LLC, Bayer HealthCare Pharmaceuticals Inc., Bayer HealthCare US Funding II LLC, Bayer HealthCare US Funding LLC, Bayer Inc., Bayer International Trade Services Corporation, Bayer Medical Care Inc., Bayer New AU M1059 USD LLC, Bayer New AU M3650 LLC, Bayer New BE M3155 LLC, Bayer New CA M5015 LLC, Bayer New CH M3868 LLC, Bayer New CZ M3204 LLC, Bayer New DE M3385 LLC, Bayer New Gewas I M3640 LLC, Bayer New Gewas II M3640 LLC, Bayer New HU M3440 LLC, Bayer New MA M3130 LLC, Bayer New MX M3640 LLC, Bayer New MY M1455 LLC, Bayer New NL M3644 LLC, Bayer New Oogst M3648 LLC, Bayer New PL M3655 LLC, Bayer New RO M3695 LLC, Bayer New RU M3708 LLC, Bayer New TH M1763 LLC, Bayer New TK M3970 LLC, Bayer New UA M3702 LLC, Bayer New UK M3939 LLC, Bayer New Veggie M3617 M5157 LLC, Bayer New Veggie Mig M3617 M5157 LLC, Bayer New ZA M3743 LLC, Bayer Overseas Trade Services Corporation, Bayer Puerto Rico Inc., Bayer U.S. LLC, Bayer US Finance II LLC, Bayer US Finance LLC, Bayer US Holding LP, Bayer West Coast Corporation, Bayer World Investments B.V., Bayer d. o. o., Bayer spol. sr. o., Bayer-Handelsgesellschaft mit beschränkter Haftung, Beeologics Admin LLC, Beeologics Holdings Limited, Beeologics LLC, Beeologics USA Inc, Berlimed S. A., Berlipharm B.V., Berlis AG, Biogenetic Technologies B.V., BlueRock Therapeutics, Care/of, Channel Bio LLC, Chemion Logistik GmbH, Collateral Therapeutics Inc., Conceptus SAS La Garenne, Cooper Land Company of New Jersey Inc., Coppertone LLC, Corn States LLC, Dihon Pharmaceutical, Dr. Scholl’s LLC, Dritte Bayer Real Estate VV GmbH & Co. KG, Erste Bayer Real Estate VV GmbH & Co. KG, Erste K-W-A Beteiligungsgesellschaft mbH, EuroServices Bayer S. L., Fünfte Bayer Real Estate VV GmbH & Co., GP Grenzach Produktions GmbH, Grass Roots Biotechnology LLC, Hornbeck Seed Company Inc., Icon Genetics, Intendis GmbH, Intraserv GmbH & Co., Jenapharm GmbH & Co. KG, KVP Pharma+Veterinär Produkte GmbH, KWA Investment II LLC Research, KWA Investment III LLC, KWA Investment IV LLC, KaNDy Therapeutics, MENADIER Heilmittel GmbH, MNL Luxembourg S. a. r. l., MONSANTO Hungaria Kft., MONSANTO Saaten GmbH, Merck-Consumer Care (MCC), MiraLAX LLC, Monsanto ACUA MHC LLC, Monsanto AG Netherlands I C.V., Monsanto AG Netherlands II C.V., Monsanto AGN Holding LLC, Monsanto Ag B.V., Monsanto Agrar Deutschland GmbH, Monsanto Agricultura España S. L., Monsanto Agricultura Italia S.p.A., Monsanto Agriculture Nigeria Limited, Monsanto Burkina Faso SARL, Monsanto CR s. r. o., Monsanto Canada ULC, Monsanto Caribe LLC, Monsanto Company, Monsanto Crop B.V., Monsanto Crop Sciences Denmark A/S, Monsanto Crop Sciences Norway A/S, Monsanto Crop Sciences Sweden A.B., Monsanto Finance SA, Monsanto Gesellschaft m. b. H., Monsanto Gida Ve Tarim Ticaret Ltd, Monsanto Grain B.V., Monsanto Great Lakes Production Co LLC, Monsanto Hawaii Production Co LLC, Monsanto Hellas Agriculturals Ltd, Monsanto Holding I C.V., Monsanto Holding II C.V., Monsanto Holding III C.V., Monsanto Holding Ukraine Ltd, Monsanto Holland B.V., Monsanto II Lda, Monsanto Illinois Production Co LLC, Monsanto Inter-America Company, Monsanto International Sarl, Monsanto Invest B.V., Monsanto Iowa Production Co LLC, Monsanto Ireland Limited, Monsanto Jordan LLC, Monsanto Kenya Ltd, Monsanto Kool BV, Monsanto LA Holdings II Co LLC, Monsanto Latin America Holdings Co LLC, Monsanto MGCV MHC LLC, Monsanto MSCV Holding LLC, Monsanto MYCV MHC LLC, Monsanto Malawi Ltd, Monsanto Missouri Production Co LLC, Monsanto NL BV, Monsanto Northern Production Co LLC, Monsanto Oogst B.V., Monsanto Operations B.V., Monsanto Polska Sp. z o. o., Monsanto Production Supply LLC, Monsanto Romania SRL, Monsanto Rus LLC, Monsanto S.A.S., Monsanto Seed Supply LLC, Monsanto Seeds LLC, Monsanto Serbia D. O. O., Monsanto Slovakia S. R. O., Monsanto South Africa (PTY) Ltd, Monsanto Southern Production Co LLC, Monsanto Tanzania Limited, Monsanto Technology International LLC, Monsanto Technology LLC, Monsanto Treasury Services SARL, Monsanto UK Limited Cambridge U. K., Monsanto Vegetable Holding LLC, Monsanto Vegetable IP Holding C.V., Monsanto Vegetable IP Management BV, Monsanto Vegetable Seed Holding LLC, Monsanto Western Production Co LLC, Monsanto Zaad B.V., Monsanto Zambia Ltd, Monsanto d. o. o., Pallas Versicherung, Pandias Re AG, Pianosa B.V., Relay Limited, SC Bayer SRL, SCEA De Ruiter Zonen Selection, Sechste Bayer Real Estate VV GmbH & Co., Seminis Vegetable Seeds U. K. Ltd, Siebte Bayer VV GmbH, Steigerwald Arzneimittelwerk GmbH, TECTRION GmbH, TOO Bayer KAZ, The Climate Corporation International SA, TravelBoard GmbH, UAB Bayer, Vierte Bayer Real Estate VV GmbH & Co., WeatherMe OÜ, Zeptosens, Zoner.ag, Zweite Bayer Real Estate VV GmbH & Co., and Zweite K-W-A Beteiligungsgesellschaft mbH.

When was Bayer Aktiengesellschaft founded?

Bayer Aktiengesellschaft was founded in 1863.

What is Bayer Aktiengesellschaft's official website?

The official website for Bayer Aktiengesellschaft is www.bayer.com.

Where are Bayer Aktiengesellschaft's headquarters?

Bayer Aktiengesellschaft is headquartered at Kaiser-Wilhelm-Allee 1, Leverkusen 2M, 51368.

How can I contact Bayer Aktiengesellschaft?

Bayer Aktiengesellschaft's mailing address is Kaiser-Wilhelm-Allee 1, Leverkusen 2M, 51368. The company can be reached via phone at 49214301, via email at [email protected], or via fax at 49-21-4306-6328.


This page was last updated on 12/6/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.